Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · November 25, 2022

Incidence of Skin Malignancies Among Patients With Vitiligo or Psoriasis Receiving Narrowband UVB Phototherapy

Photodermatology, Photoimmunology & Photomedicine


Additional Info

Photodermatology, Photoimmunology & Photomedicine
Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308nm/311nm): a retrospective review of 3730 patients
Photodermatol Photoimmunol Photomed 2022 Nov 07;[EPub Ahead of Print], BKY Chia, YW Yew, X Zhao, WS Chong, TGS Thng

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading